Observational studyInternational journal of chronic obstructive pulmonary disease2017
A nationwide structure for valid long-term oxygen therapy: 29-year prospective data in Sweden.
Observational study in International journal of chronic obstructive pulmonary disease, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
22 citing papers in PubMed.
- Oxygen therapy in interstitial lung disease - navigating benefit and burden.Current opinion in pulmonary medicine · 2026Review
- Article
- Similar risk of hospitalization and mortality for patients continuing and discontinuing LTOT.Respiratory research · 2025Observational
- FlexO2: A patient-controlled oxygen flow selector improving autonomy and daily function in long-term oxygen therapy (LTOT).Respiratory research · 2025Article
- Conducting a registry-based randomised trial (REDOX) in chronic respiratory failure: experiences and advice.European clinical respiratory journal · 2025Review
- Smoking and home oxygen therapy: a review and consensus statement from a multidisciplinary Swedish taskforce.European respiratory review : an official journal of the European Respiratory Society · 2024Review
- Thoughts on the end of life in patients with oxygen-dependent chronic obstructive pulmonary disease: A qualitative interview study.Nursing open · 2023Article
- Quality of Domiciliary Oxygen Therapy in Adults with Chronic Respiratory Diseases- Results of a Multicenter Cross-Sectional Study in Germany.Deutsches Arzteblatt international · 2022Article
- Adverse Effects, Smoking, Alcohol Consumption, and Quality of Life during Long-Term Oxygen Therapy: A Nationwide Study.Annals of the American Thoracic Society · 2022Article
- Observational
- Feasibility of completing Multidimensional Dyspnea Profile and Dyspnea-12 over the telephone in patients with oxygen-dependent disease.BMJ open respiratory research · 2021Article
- Indications and patterns of use of benzodiazepines and opioids in severe interstitial lung disease: a population-based longitudinal study.ERJ open research · 2021Article
- Validation of the Swedevox registry of continuous positive airway pressure, long-term mechanical ventilator and long-term oxygen therapy.ERJ open research · 2021Article
- Course of DISease In patients reported to the Swedish CPAP Oxygen and VEntilator RegistrY (DISCOVERY) with population-based controls.BMJ open · 2020Article
- Home Oxygen Therapy for Adults with Chronic Lung Disease. An Official American Thoracic Society Clinical Practice Guideline.American journal of respiratory and critical care medicine · 2020Article
- Current Situation of Home Oxygen Therapy for Chronic Obstructive Pulmonary Disease Patients in Korea.Journal of Korean medical science · 2020Article
- Oxygen therapy in COPD and interstitial lung disease: navigating the knowns and unknowns.ERJ open research · 2019Review
- Patient Experience in Home Respiratory Therapies: Where We Are and Where to Go.Journal of clinical medicine · 2019Review
- Patient registries for home oxygen research and evaluation.International journal of chronic obstructive pulmonary disease · 2019Article
- Daily duration of long-term oxygen therapy and risk of hospitalization in oxygen-dependent COPD patients.International journal of chronic obstructive pulmonary disease · 2018Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundLong-term oxygen therapy (LTOT) improves prognosis in COPD with severe hypoxemia. However, adherence to criteria for eligibility and quality of LTOT is often insufficient and varies between countries. The aim of this study was to evaluate a national structure for prescription and management of LTOT over three decades in Sweden.
methodsThe study was a prospective, population-based study of 23,909 patients on LTOT from 1987 to 2015 in the Swedish National Register of Respiratory Failure (Swedevox). We assessed the prevalence, incidence, and structure of LTOT; completeness of registration in Swedevox; and validity of prescription and management of LTOT in Sweden according to seven published quality indicators.
resultsLTOT was prescribed by 48 respiratory or medicine units and managed mainly by specialized oxygen nurses. Swedevox had a stable completeness of 85% of patients starting LTOT since 1987. The national incidence of LTOT increased from 3.9 to 14.7/100,000 inhabitants over the time period. In 2015, 2,596 patients had ongoing therapeutic LTOT in the registry, a national prevalence of 31.6/100,000. Adherence to prescription recommendations and fulfillment of quality criteria was stable or improved over time. Of patients starting LTOT in 2015, 88% had severe hypoxemia (partial pressure of arterial oxygen [PaO
conclusionWe present a structure for prescription, management, and follow-up of LTOT. The national registry effectively monitored adherence to prescription recommendations and most likely contributed to improved quality of care.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.